ClinicalTrials.Veeva

Menu

Ecological Momentary Assessment and Physical Activity in Patients With Inflammatory Rheumatic Diseases (DYNAMIC)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Not yet enrolling

Conditions

Rheumatoid Arthritis &Amp;Amp;Amp; Other Inflammatory Polyarthropathies
Spondyloarthritis (SpA)

Treatments

Other: Ecological Momentary Assessment

Study type

Observational

Funder types

Other

Identifiers

NCT07167784
EssaiClinique_DYNAMIC

Details and patient eligibility

About

Chronic inflammatory rheumatic diseases (IRDs), such as rheumatoid arthritis and spondyloarthritis, can cause pain, fatigue, and mobility issues, significantly impacting patients' quality of life. Physical activity is an important part of managing these conditions, as it helps reduce pain, maintain mobility, and prevent complications. However, many patients struggle to stay active due to pain and fatigue. Understanding these challenges better could lead to improved support and interventions.

This study explores a new way to monitor the daily experiences of patients with IRDs using Ecological Momentary Assessment (EMA), a method that collects real-time data through a mobile app. The study will also use actimeters-wearable devices that track physical activity. Over 14 days, participants will answer short surveys on their phone and wear an actimeter to provide insights into how fatigue, pain, mood, and physical activity levels change throughout the day.

Before using this approach in a larger study, we need to make sure it is practical and acceptable for patients. This pilot study will assess whether participants find the mobile app and actimeter easy to use, how often they respond to surveys, and whether frequent reminders affect their willingness to participate. The study will also examine the immediate and delayed effects of different symptoms on physical activity and explore factors that influence patient engagement with the protocol.

By identifying potential barriers and solutions, this research will help refine future studies and improve the way we monitor and support people with IRDs in staying active while managing their symptoms.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adults (≥18 years) with a confirmed diagnosis of CIRDs, including RA or SpA, established by a rheumatologist, are eligible for inclusion. Participants must be able to understand and consent to the study protocol, be affiliated with a social security system, and have access to a digital device with internet access (e.g., smartphone or tablet).

Non-inclusion Criteria:

  • Insufficient proficiency in the French language; legal incapacity or deprivation of liberty; major cognitive impairment incompatible with repeated questionnaire completion (e.g., Alzheimer's disease); pregnant or breastfeeding women, as well as individuals with a history of alcohol or substance abuse, or severe psychiatric disorders that could affect adherence to the protocol or the reliability of collected data, are also excluded.

Trial contacts and locations

1

Loading...

Central trial contact

Monique Mendelson, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems